Knowing More Matters

what is the
PCRplus advantage?

PCRplus is an elevated category of PCR testing because it combines the following five advantages:

Accuracy

Results you can rely on.

speed

Don’t wait days. Same-day results.

flexibility

Results anytime, anywhere.

quality

A track record of results you can trust.

simplicity

Easy steps from test to result.

Cepheid, with its GeneXpert® systems and diverse menu of PCR tests, is proud to offer PCRplus advantage across the  healthcare continuum. The company’s solutions deliver actionable results where they are needed most – from central laboratories  and hospitals to near-patient settings.

Experience the PCRplus Advantage

The PCRplus advantage delivers uncompromised accuracy, speed, flexibility, and simplicity across five test portfolios including respiratory health, sexual health, virology, oncology, and critical infectious diseases.

Advantages of PCR testing as compared to antigen testing

Is it COVID-19, RSV, or the Flu?

#carousel-content-4 .carousel-layout > .row > div[class*="col"]:nth-child(n + ${ activeRow * colCount + 1 }$), #carousel-content-4 .carousel-layout > .row > div[class*="col"]:nth-last-child(n + ${ storyCount - (activeRow - 1) * colCount + 1}$) { visibility: hidden; max-height: 0px; overflow: hidden; margin-bottom: 0; opacity: 0; left: 30px; }

Enabling Global Health Solutions

Cepheid embraces its responsibility to continue critical test development and enable platform access beyond the traditional laboratory.

Success Stories

RESPIRATORY TESTING

Tuberculosis Doctor  & Survivor Shares Her Story

Dr. Sifumba is a medical doctor, a survivor of both COVID-19 and multidrug-resistant tuberculosis (MDR-TB), and a health activist living in Johannesburg, South Africa. She shares her story and her dedication to improving access to PCR testing for patients and health workers across the globe.

Watch Video

WATCH VIDEO: CANCER MONITORING

Chronic Myeloid Leukemia Survivor Shares His Story

Diagnosed 27 years ago with chronic myeloid leukemia, a cancer of the blood, Mel Mann was told that his illness was terminal. He found new hope through PCR monitoring, enabling quicker results and faster treatment adjustments to effectively manage the disease and improve quality of life.